A single dose of zoledronic acid 5 mg achieves more sustained biochemical remission versus daily 30mg risedronate in patients with Paget's disease

Brown, J., Lyles, K., Fraser, W., Reid, I., Hosking, D., Devogelaer, J.-P., Moniz, C., Hooper, M., Saidi, Y., Su, G., Pak, J., Davis, J., Fashola, T., Krasnow, J., Zelenakas, K., & Miller, P. (2006). A single dose of zoledronic acid 5 mg achieves more sustained biochemical remission versus daily 30mg risedronate in patients with Paget’s disease. Osteoporosis International : with other metabolic bone diseases, 17, S255-S256. https://hdl.handle.net/2078.5/139416 (Original work published 2006)